Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile

Detalhes bibliográficos
Autor(a) principal: Martins, Heloise Helena [UNIFESP]
Data de Publicação: 2011
Outros Autores: Alonso, Neide Barreira [UNIFESP], Vidal-Dourado, Marcos [UNIFESP], Carbonel, Thiago Delfino [UNIFESP], Araujo Filho, Gerardo Maria de [UNIFESP], Caboclo, Luís Otávio Sales Ferreira [UNIFESP], Yacubian, Elza Márcia Targas [UNIFESP], Guilhoto, Laura Maria de Figueiredo Ferreira [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/34163
http://dx.doi.org/10.1016/j.yebeh.2011.08.005
Resumo: We report the results of administration of the Portuguese-Brazilian translation of the Liverpool Adverse Events Profile (LAEP) to 100 patients (mean age = 34.5, SD = 12.12; 56 females), 61 with symptomatic partial epilepsy (SPE) and 39 with idiopathic generalized epilepsy (ICE) (ILAE, 1989) who were on a stable antiepileptic drug (AED) regimen and being treated in a Brazilian tertiary epilepsy center. Carbamazepine was the most commonly used AED (43.0%), followed by valproic acid (32.0%). Two or more AEDs were used by 69.0% of patients. the mean LAEP score (19 questions) was 37.6 (SD = 13.35). the most common adverse effects were sleepiness (35.0%), memory problems (35.0%), and difficulty in concentrating (25.0%). Higher LAEP scores were associated with polytherapy with three or more AEDs (P=0.005), female gender (P<0.001), older age (P<0.001), and uncontrolled seizures (P = 0.045). the intraclass coefficient (test-retest reliability) for LAEP overall score was 0.848 (95% CI = 0.782-0.895), with a range from 0.370 (unsteadiness) to 0.750 (memory problems). Cronbach's alpha coefficient (internal consistency) was 0.903. the LAEP was highly correlated with Quality of Life in Epilepsy-31 inventory (r = -0.804, P>0.001) and Hospital Anxiety and Depression Scale (Depression: r = 0.637, P<0.001; Anxiety: r = 0.621, P<0.001) dimensions. LAEP overall scores were similar in people with SPE and IGE and were not helpful in differentiating adverse effects in these two groups. Clinical variables that influenced global LAEP were seizure frequency (P = 0.050) and generalized tonic-clonic seizures in the last month (P = 0.031) in the ICE group, and polytherapy with three or more AEDs (P = 0.003 and P = 0.003) in both ICE and SPE groups. (C) 2011 Elsevier Inc. All rights reserved.
id UFSP_cec27b671e2f90f50b8dd9645b372604
oai_identifier_str oai:repositorio.unifesp.br:11600/34163
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Martins, Heloise Helena [UNIFESP]Alonso, Neide Barreira [UNIFESP]Vidal-Dourado, Marcos [UNIFESP]Carbonel, Thiago Delfino [UNIFESP]Araujo Filho, Gerardo Maria de [UNIFESP]Caboclo, Luís Otávio Sales Ferreira [UNIFESP]Yacubian, Elza Márcia Targas [UNIFESP]Guilhoto, Laura Maria de Figueiredo Ferreira [UNIFESP]Universidade Federal de São Paulo (UNIFESP)2016-01-24T14:17:20Z2016-01-24T14:17:20Z2011-11-01Epilepsy & Behavior. San Diego: Academic Press Inc Elsevier Science, v. 22, n. 3, p. 511-517, 2011.1525-5050http://repositorio.unifesp.br/handle/11600/34163http://dx.doi.org/10.1016/j.yebeh.2011.08.005WOS000296826700017.pdf10.1016/j.yebeh.2011.08.005WOS:000296826700017We report the results of administration of the Portuguese-Brazilian translation of the Liverpool Adverse Events Profile (LAEP) to 100 patients (mean age = 34.5, SD = 12.12; 56 females), 61 with symptomatic partial epilepsy (SPE) and 39 with idiopathic generalized epilepsy (ICE) (ILAE, 1989) who were on a stable antiepileptic drug (AED) regimen and being treated in a Brazilian tertiary epilepsy center. Carbamazepine was the most commonly used AED (43.0%), followed by valproic acid (32.0%). Two or more AEDs were used by 69.0% of patients. the mean LAEP score (19 questions) was 37.6 (SD = 13.35). the most common adverse effects were sleepiness (35.0%), memory problems (35.0%), and difficulty in concentrating (25.0%). Higher LAEP scores were associated with polytherapy with three or more AEDs (P=0.005), female gender (P<0.001), older age (P<0.001), and uncontrolled seizures (P = 0.045). the intraclass coefficient (test-retest reliability) for LAEP overall score was 0.848 (95% CI = 0.782-0.895), with a range from 0.370 (unsteadiness) to 0.750 (memory problems). Cronbach's alpha coefficient (internal consistency) was 0.903. the LAEP was highly correlated with Quality of Life in Epilepsy-31 inventory (r = -0.804, P>0.001) and Hospital Anxiety and Depression Scale (Depression: r = 0.637, P<0.001; Anxiety: r = 0.621, P<0.001) dimensions. LAEP overall scores were similar in people with SPE and IGE and were not helpful in differentiating adverse effects in these two groups. Clinical variables that influenced global LAEP were seizure frequency (P = 0.050) and generalized tonic-clonic seizures in the last month (P = 0.031) in the ICE group, and polytherapy with three or more AEDs (P = 0.003 and P = 0.003) in both ICE and SPE groups. (C) 2011 Elsevier Inc. All rights reserved.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Universidade Federal de São Paulo, Dept Neurol, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Neurol, São Paulo, BrazilWeb of Science511-517engElsevier B.V.Epilepsy & Behaviorhttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyinfo:eu-repo/semantics/openAccessLiverpool Adverse Events ProfileAntiepileptic drugsEpilepsyAdverse effectsSymptomatic partial epilepsyIdiopathic generalized epilepsyValidationAre adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profileinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlereponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000296826700017.pdfapplication/pdf666093${dspace.ui.url}/bitstream/11600/34163/1/WOS000296826700017.pdf97efb5d8765f4c10b92fbda30647b28eMD51open accessTEXTWOS000296826700017.pdf.txtWOS000296826700017.pdf.txtExtracted texttext/plain42154${dspace.ui.url}/bitstream/11600/34163/2/WOS000296826700017.pdf.txt961289cf601d60b8311afc52b5c1d5d1MD52open access11600/341632022-07-08 10:22:10.688open accessoai:repositorio.unifesp.br:11600/34163Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-05-25T12:17:46.351503Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
title Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
spellingShingle Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
Martins, Heloise Helena [UNIFESP]
Liverpool Adverse Events Profile
Antiepileptic drugs
Epilepsy
Adverse effects
Symptomatic partial epilepsy
Idiopathic generalized epilepsy
Validation
title_short Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
title_full Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
title_fullStr Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
title_full_unstemmed Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
title_sort Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? the Portuguese-Brazilian validation of the Liverpool Adverse Events Profile
author Martins, Heloise Helena [UNIFESP]
author_facet Martins, Heloise Helena [UNIFESP]
Alonso, Neide Barreira [UNIFESP]
Vidal-Dourado, Marcos [UNIFESP]
Carbonel, Thiago Delfino [UNIFESP]
Araujo Filho, Gerardo Maria de [UNIFESP]
Caboclo, Luís Otávio Sales Ferreira [UNIFESP]
Yacubian, Elza Márcia Targas [UNIFESP]
Guilhoto, Laura Maria de Figueiredo Ferreira [UNIFESP]
author_role author
author2 Alonso, Neide Barreira [UNIFESP]
Vidal-Dourado, Marcos [UNIFESP]
Carbonel, Thiago Delfino [UNIFESP]
Araujo Filho, Gerardo Maria de [UNIFESP]
Caboclo, Luís Otávio Sales Ferreira [UNIFESP]
Yacubian, Elza Márcia Targas [UNIFESP]
Guilhoto, Laura Maria de Figueiredo Ferreira [UNIFESP]
author2_role author
author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Martins, Heloise Helena [UNIFESP]
Alonso, Neide Barreira [UNIFESP]
Vidal-Dourado, Marcos [UNIFESP]
Carbonel, Thiago Delfino [UNIFESP]
Araujo Filho, Gerardo Maria de [UNIFESP]
Caboclo, Luís Otávio Sales Ferreira [UNIFESP]
Yacubian, Elza Márcia Targas [UNIFESP]
Guilhoto, Laura Maria de Figueiredo Ferreira [UNIFESP]
dc.subject.eng.fl_str_mv Liverpool Adverse Events Profile
Antiepileptic drugs
Epilepsy
Adverse effects
Symptomatic partial epilepsy
Idiopathic generalized epilepsy
Validation
topic Liverpool Adverse Events Profile
Antiepileptic drugs
Epilepsy
Adverse effects
Symptomatic partial epilepsy
Idiopathic generalized epilepsy
Validation
description We report the results of administration of the Portuguese-Brazilian translation of the Liverpool Adverse Events Profile (LAEP) to 100 patients (mean age = 34.5, SD = 12.12; 56 females), 61 with symptomatic partial epilepsy (SPE) and 39 with idiopathic generalized epilepsy (ICE) (ILAE, 1989) who were on a stable antiepileptic drug (AED) regimen and being treated in a Brazilian tertiary epilepsy center. Carbamazepine was the most commonly used AED (43.0%), followed by valproic acid (32.0%). Two or more AEDs were used by 69.0% of patients. the mean LAEP score (19 questions) was 37.6 (SD = 13.35). the most common adverse effects were sleepiness (35.0%), memory problems (35.0%), and difficulty in concentrating (25.0%). Higher LAEP scores were associated with polytherapy with three or more AEDs (P=0.005), female gender (P<0.001), older age (P<0.001), and uncontrolled seizures (P = 0.045). the intraclass coefficient (test-retest reliability) for LAEP overall score was 0.848 (95% CI = 0.782-0.895), with a range from 0.370 (unsteadiness) to 0.750 (memory problems). Cronbach's alpha coefficient (internal consistency) was 0.903. the LAEP was highly correlated with Quality of Life in Epilepsy-31 inventory (r = -0.804, P>0.001) and Hospital Anxiety and Depression Scale (Depression: r = 0.637, P<0.001; Anxiety: r = 0.621, P<0.001) dimensions. LAEP overall scores were similar in people with SPE and IGE and were not helpful in differentiating adverse effects in these two groups. Clinical variables that influenced global LAEP were seizure frequency (P = 0.050) and generalized tonic-clonic seizures in the last month (P = 0.031) in the ICE group, and polytherapy with three or more AEDs (P = 0.003 and P = 0.003) in both ICE and SPE groups. (C) 2011 Elsevier Inc. All rights reserved.
publishDate 2011
dc.date.issued.fl_str_mv 2011-11-01
dc.date.accessioned.fl_str_mv 2016-01-24T14:17:20Z
dc.date.available.fl_str_mv 2016-01-24T14:17:20Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Epilepsy & Behavior. San Diego: Academic Press Inc Elsevier Science, v. 22, n. 3, p. 511-517, 2011.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/34163
http://dx.doi.org/10.1016/j.yebeh.2011.08.005
dc.identifier.issn.none.fl_str_mv 1525-5050
dc.identifier.file.none.fl_str_mv WOS000296826700017.pdf
dc.identifier.doi.none.fl_str_mv 10.1016/j.yebeh.2011.08.005
dc.identifier.wos.none.fl_str_mv WOS:000296826700017
identifier_str_mv Epilepsy & Behavior. San Diego: Academic Press Inc Elsevier Science, v. 22, n. 3, p. 511-517, 2011.
1525-5050
WOS000296826700017.pdf
10.1016/j.yebeh.2011.08.005
WOS:000296826700017
url http://repositorio.unifesp.br/handle/11600/34163
http://dx.doi.org/10.1016/j.yebeh.2011.08.005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Epilepsy & Behavior
dc.rights.driver.fl_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 511-517
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/34163/1/WOS000296826700017.pdf
${dspace.ui.url}/bitstream/11600/34163/2/WOS000296826700017.pdf.txt
bitstream.checksum.fl_str_mv 97efb5d8765f4c10b92fbda30647b28e
961289cf601d60b8311afc52b5c1d5d1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460272936058880